Quick Read - Apple shares rose 1.7% on the SpaceX phone rumor, but Musk explicitly targets the $26.6B App Store as the real motivation for a proprietary OS. - SpaceX's 7.3% drop masked a bigger story: FCC-approved spectrum, Starlink retail wireless, and the xAI merger form a...</
For millions of retirees relying on Social Security, understanding the rules of this popular benefits program is crucial. Unfortunately, some rules are confusing and work differently than you might expect In fact, there's one specific regulation that surprises retir
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has been kept on a 'buy' rating by Citi, which pointed to a run of late-stage drug trial results in the second half of the year as the key driver for the shares. The Wall Street bank was previewing second-quarter results from the Anglo
Micron shares rise 2.6% in premarket trading Micron Technology and Qualcomm are under watch by Citi. Micron shares rose 2.6% in premarket trading, while Qualcomm rose 1.3%. The catalyst watch is split, with an upside watch on Micron and a downside watch on Qualco
Strong corporate earnings growth outpaces stock price gains, pushing the S&P 500’s valuation multiple lower despite high investor enthusiasm. The S&P 500’s forward price-to-earnings ratio has fallen below its 2026 starting level, even as stock prices remain elevated. Rapid
The chipmaker aims to raise $28 billion via ADRs, marking one of the largest share sales ever, with trading set to begin July 10. SK Hynix launched a $28 billion American depositary receipt offering on Nasdaq, targeting funds for semiconductor capacity expansion. The deal,
Lower oil prices and easing rate hike bets lift U.S. equity futures before key AI sector earnings reports this week. U.S. equity futures rose on Monday, with the S&P 500 up 0.5% and Nasdaq futures climbing 1.1%, as oil prices retreated on expectations of increased supply.
Investing in biotechnology requires a balance between groundbreaking scientific innovation and the realities of clinical development. Choosing between CRISPR Therapeutics (NASDAQ:CRSP) and Viking Therapeutics (NASDAQ:VKTX) involves comparing established gene-editing leader
Here Are Monday’s Best Wall Street Analyst Research Calls: Agnico Eagle Mines, Datadog, Delta Air Lines, Gilead Sciences, Okta, Pfizer, Regions Financial, T-Mobile, and More Quick Read - T-Mobile (TMUS) and Gilead Sciences (GILD) both earned Buy upgrades Monday, with Bank of...</
Space stocks are getting a lot of attention this summer. Some of that can be attributed to the buzz surrounding Space Exploration Technologies (NASDAQ: SPCX) and its record-setting IPO last month that raised nearly $86 billion SpaceX already sports a market capitali
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.